Skip to content
Home/Companies/MedTech/ReCor Medical

ReCor Medical

MedTech·United States·Exited 2018·Held 2yr
Entry
2016
Hold
2yr
Exit
2018

Who owns ReCor Medical?

ReCor Medical is an American MedTech company, now owned by Otsuka Holdings, which acquired it in 2018 from Sofinnova Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC

Key facts

HQUnited States
SectorMedTech
Exit Type
Trade Sale
Buyer
Otsuka Holdings
Exit Year
2018

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to Ironwood Pharmaceuticals
Breath Therapeutics
Exited 2019
BiotechGermany· 2016
to Zambon
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to Novo Nordisk
Delinia
Exited 2017
BiotechUK· 2016
to Celgene
ENYO Pharma
ENYO Pharma
Active
BiotechFrance· 2016
BiovelocITA
Active
BiotechItaly· 2015

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns ReCor Medical?

ReCor Medical is now owned by Otsuka Holdings, which acquired it in 2018 from Sofinnova Partners.

When did Otsuka Holdings acquire ReCor Medical?

Otsuka Holdings acquired ReCor Medical in 2018, buying from Sofinnova Partners.

Who did ReCor Medical sell to?

Sofinnova Partners sold ReCor Medical to Otsuka Holdings in 2018 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue